Post marketing Studies and research is becoming increasingly important for maintaining drug approval, achieving appropriate reimbursement and optimised clinical access. We provide tailored consulting and writing of high quality documents for your complete post marketing program.
Our experience includes projects on post marketing safety and comparative effectiveness data, outcomes research, Quality of Life (QOL), health economics, real life drug use.
We can assess and advise you on the types of studies that will generate the documents needed to meet your post marketing goals and provide you with all documents.

Documentation for:

• Post marketing studies and development plans.
• Phase 4 (late phase) Clinical trials.
• Comparative effectiveness research.
• Observational studies.
• Patient registries.